SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN) announced today that it is currently in negations with four companies to provide storage for peripheral blood related stem cell specimens. It is anticipated that, in the event that negotiations are successful, an excess of 15,000 specimens may be stored by the Company in the first year generating average revenue of $650 per specimen.
